2m 2m 2m 2m 2m 2m 2m
PROKIDNEY-A (PROK)
NASDAQ
$1.80-$0.03 (-1.37%)
Price as of Jun 23, 2026 4:10 PM EDT- $373.5MMarket Cap
- 200.33%1-Year Change
- BiotechnologyIndustry
PROKIDNEY-A (PROK)
$1.80-$0.03 (-1.37%)
PROK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.82 | ||
Change | -$0.01 (-0.55%) | ||
Open | $1.83 | ||
High | $1.93 | ||
Low | $1.80 | ||
Previous Close | $1.83 | ||
Volume | 728,575 | ||
30-Day Average Volume | 937,578 | ||
1-Week Change | 8.98% | ||
1-Month Change | 4.00% | ||
1-Year Change | 200.33% | ||
3-Year Change | -83.60% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 205.2M | ||
Total Assets | $292.8M | ||
Market Cap | $373.5M | ||
Enterprise Value | $271.6M | ||
Period: QTR TTM FY | |||
Revenue | $226,000.00 | ||
Net Income | -$20.0M | ||
Free Cash Flow | -$45.5M | ||
EBIT | -$20.0M | ||
EBITDA | -$18.4M | ||
Net Working Capital | $209.0M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | 1,202 | ||
P/B | -0 | ||
P/E | -13 | ||
PEG | 5 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue